SLC5A2 and diabetes mellitus: Diabetes mellitus itself, rather than SGLT2 Inhibitors, is the major risk factor for development of Fournier's Gangrene, as supported by data from our own study with over 40% of patients having diabetes at the time of their hospital admission.